| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
Okt 17, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Okt 18, 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
Okt 17, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Okt 18, 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
Okt 17, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Okt 18, 2024 |
| Sr. Spec. DDIT IES Supplier Management |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Informationstechnologie |
Okt 18, 2024 |
| Senior Specialist DDIT OPS Mfg Site IT |
Sasayama |
Japan |
Operations |
CTS |
Informationstechnologie |
Jul 22, 2024 |
| Sr. Spec. IT Solution Delivery |
INSURGENTES |
Mexiko |
Operations |
CTS |
Informationstechnologie |
Jul 15, 2024 |
| Chef, Communications corporatives |
Montreal |
Kanada |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Okt 21, 2024 |
| Public Affairs Manager |
Ankara Gimat |
Türkei |
International |
Innovative Medicines |
Communications & Public Affairs |
Sep 13, 2024 |
| Patient Engagement Lead |
İstanbul Kavacık |
Türkei |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Sep 03, 2024 |
| Communication & Patient Advocacy Manager (f/m/d) |
Vienna |
Österreich |
International |
CTS |
Communications & Public Affairs |
Sep 24, 2024 |
| Manager, Post Production & Video Services |
Hyderabad (Office) |
Indien |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Okt 04, 2024 |
| Lead - Government Affairs |
Delhi (Office) |
Indien |
International |
Innovative Medicines |
Communications & Public Affairs |
Okt 15, 2024 |
| Comms & Engagement Manager |
Amsterdam |
Niederlande |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Okt 16, 2024 |
| Executive Director, Therapy Area Communications and Patient Advocacy |
Basel (City) |
Schweiz |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Okt 16, 2024 |
| Associate Director, R&D Portfolio and Engagement - Communications |
Cambridge (Massachusetts) |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Okt 08, 2024 |
| Associate Director, Finance and Strategy & Growth Activation Communications |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Okt 08, 2024 |
| (Sr.) Public Affairs Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Communications & Public Affairs |
Okt 20, 2024 |
| Director of Global & Swiss Media & Editorial |
Basel (City) |
Schweiz |
Corporate |
CTS |
Communications & Public Affairs |
Okt 18, 2024 |
| Manager, Corporate Communications |
Montreal |
Kanada |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Okt 21, 2024 |
| Associate Director, Business Transformation & Engagement |
Barcelona Gran Vía |
Spanien |
Development |
Innovative Medicines |
Communications & Public Affairs |
Okt 23, 2024 |
| Director of Commercial Policy Communications and Media Relations, Europe |
Basel (City) |
Schweiz |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Okt 24, 2024 |
| Associate Director, Corporate Event Marketing |
East Hanover (New Jersey) |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Okt 22, 2024 |
| Associate Director, Political Affairs & Insights |
Washington, DC |
USA |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Okt 22, 2024 |
| EA & Program Coordinator |
Beijing (Beijing) |
China |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Okt 22, 2024 |
| Government Affairs Manager |
Moscow (City) |
Russische Foed. |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Okt 22, 2024 |
| Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Communications & Public Affairs |
Jul 09, 2024 |